Transcarent vs Ubie (2026)
Both stand between a person with a problem and the health system, and they are paid by completely different parties. Transcarent is bought by self insured employers and health plans, with generative navigation across benefits, clinical guidance and care access reaching more than twenty million members, and it publishes better governance material than most of this index. Ubie is free and unregistered, a symptom checker covering more than a thousand conditions built on published literature under physician supervision. The difference shows up in what each optimises. A benefits navigator has a legitimate interest in where a member is directed, since network and cost follow from it. A free symptom checker does not, but it also cannot book anything or know what a member's plan covers. Neither publishes performance across health literacy or language, which is where both fail people most quietly.
- It is bought by employers and health plans rather than providers, reaching more than twenty million members across more than seventeen hundred clients, which is a distribution position no clinical vendor matches.
- The governance disclosure is among the better ones in this index, with real certifications described precisely and a named accountable owner.
- Navigation across benefits, clinical guidance and care access in one experience is a different job from answering a clinical question, and for a member who does not know where to start it is the more useful one.
- It is free with no registration, so an organisation can point people at it without procuring anything and a patient can use it without an account.
- Coverage spans more than a thousand conditions from an adaptive questionnaire built on published literature under physician supervision, with an unusually strong evidence posture for a consumer product.
- It answers the question the person actually has, what might be wrong and where to go, rather than routing them through a benefits structure first.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Transcarent and Ubie are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Transcarent | Ubie |
|---|---|---|
| Primary category | Healthcare Administrative Automation | Clinical Decision Support |
| Founded | Not recorded | 2017 |
| Headquarters | San Francisco, California | Tokyo, Japan |
| Website | transcarent.com | ubiehealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for Transcarent on any axis it scores. Set against Ubie, Transcarent grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Ubie its top capability grade on AI Centrality, Clinical and Operational Evidence and Setting and Specialty Coverage. Set against Transcarent, Ubie grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Transcarent or Ubie?
On the axes where the AI Health Index separates them, Transcarent grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture, and Ubie grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Transcarent leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Transcarent and Ubie differ most?
The widest separation the AI Health Index records between Transcarent and Ubie is on AI Centrality, where Transcarent grades C and Ubie grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Transcarent and Ubie grade the same?
The AI Health Index grades Transcarent and Ubie the same on AI Liability and Recourse and Deployment Model and Data Residency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Transcarent added agentic capabilities to its navigation experience in January 2026 and publishes no escalation criteria, confidence threshold or oversight design for them, which matters because navigation that acts is a different product from navigation that informs. Ubie's consumer product collects sex, age and history under a structure a buyer should understand before directing patients to it.
Neither vendor publishes a subgroup performance analysis, and both are answering people describing symptoms in their own words, where health literacy and language shape what the system understands and therefore where the person is sent.